April 15, 2026- Cepheid and Oxford Nanopore Technologies, a company delivering a new generation of nanopore-based molecular sensing technology for real-time genomic analysis, announced an expansion of their partnership to develop a workflow for rapid bacterial and fungal pathogen identification. Following a successful phase one collaboration announced at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2025, the companies are advancing to the next phase of development, building on a promising beta solution already in use by researchers.
